Health stocks boost Wall Street; energy a drag

UBS Raises Price Target on UnitedHealth Group (UNH) Following Investor Day

UBS reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $193.00 (from $180.00), following the company's investor day. UNH expects its Medicare Advantage enrollment to grow by 700-800K lives in 2017, a 19-22% Y/Y increase. UBS raised 2016 EPS estimates to $9.45 and... More

Leerink Partners Raises Price Target on UnitedHealth Group (UNH) to $195; Reiterates Outperform

Leerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $195.00 (from $185.00), following a company update. EPS guidance of $9.30 - $9.60 came in better than the Street expectation of $9.16. The EPS upside is driven by better than expected top-line growth in MA, and Optum as well as the ObamaCare tax holiday.

Analyst Ana Gupte, commented, "We remain bullish on UNH (OP) and reiterate our top pick status on the name while raising estimates and PT to $195. In addition to surprising meaningfully to the upside on 2017 guidance,... More

Mizuho Securities Reiterates Buy on Tiffany & Co. (TIF) Following 3Q Report

Mizuho Securities reiterated a Buy rating and $82.00 price target on Tiffany & Co. (NYSE: TIF) following the company's 3Q earnings report. TIF reported EPS of $0.76, above the Streets estimate of $0.67. Management reiterated prior guidance for MSD% decline in EPS, which implies FY16 EPS of $3.61-3.68,... More

Mizuho Securities Remains Bullish on Mallinckrodt (MNK) Following Strong 4Q

Mizuho Securities reiterated a Buy rating and $87.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. MNK reported revenues of $887.2M and adjusted EPS of $2.04, both ahead of consensus estimates of $832.1M and $1.90. Total branded sales of $633.1M outperformed consensus estimates of $596.6M.

Analyst Irina Koffler commented,... More